| 摘要 |
<p>The invention relates to the use of cpn 10 from Mycobacterium tuberculosis, or functionally equivalent molecules of fragments thereof, in the prevention and/or treatment of allergic conditions such as asthma, rhinitis/hay fever, eczema and anaphylaxis, which conditions are associated with an underlying Th2 cell over-reactivity, or cancerous conditions.</p> |
